Cash Ratio Analysis of Silverback Therapeutics Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Cash Ratio of SPRY
Dec-23
95.51
Excellent Cash Ratio
Dec-22
50.40
Excellent Cash Ratio
Growth
89.50
%
Cash Ratio Analysis of Silverback Therapeutics Inc
Cash Ratio of Silverback Therapeutics Inc with value of 95.51 indicates that a company has generated more cash in a period than what is needed to pay off its current liabilities.
Cash Ratio of SPRY rose handsomely by 89.50 % this year.
Cash Ratio of SPRY trending up for at least three Years.
Cash Ratio with value of 0.557 was lowest in Year Dec-19 in last Five Years.
Latest Cash Ratio with value of 95.51 is Greater than Average Cash Ratio of 31.36 in last five years.
Other Cash Ratio Related Info of SPRY that may interest you.
Silverback Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
SPRY8.418.66 2.89 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents.   more ..
Cash Ratio Formula
Cash Ratio Related Ratios
CurrentRatioQuickRatioDebtToEquityRatio
Tsr Stability Index
No Significant Stability
FY - Historical Cash Ratio of Silverback Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
Cash Ratio95.5150.407.342.990.557
Change89.50 %587.00 %145.63 %436.69 %
FY Chart of Cash Ratio of Silverback Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)